After 1 week of 16:8 fasting, any scale change is usually modest and may include water weight, not just fat loss. Clinical trials suggest time-restricted eating can help some people lose weight over weeks to months, but results depend on total calories, food quality, starting weight, sleep, activity, and medical history 1, 2, 3.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What results are realistic after 1 week of 16:8 fasting?
16:8 intermittent fasting may lead to a small scale change in the first week, but that number is not a clean measure of fat loss. Most human trials of time-restricted eating measure outcomes over weeks to months, not 7 days 1, 2.
Why the first week often shows water-weight changes
When you shift meal timing, you may also change carbohydrate intake, salt intake, meal size, and late-night snacks. Those changes can affect water storage and food volume in the gut, so the scale may move before body fat changes much.
That is why a 1-week result can look better or worse than the real trend. A lower number may include water loss; a higher number may reflect sodium, constipation, soreness from new exercise, or a larger meal the day before.
Why fat loss usually takes longer than 7 days
Fat loss needs a sustained energy gap over time. A systematic review found that intermittent fasting can produce weight loss, but results vary by fasting method, diet quality, study length, and adherence 3.
The TREAT randomized clinical trial studied time-restricted eating in adults with overweight or obesity and did not show a clearly superior weight-loss effect compared with the control condition over the study period 1. That does not mean 16:8 cannot help; it means the fasting window alone is not magic.
What a healthy first-week goal should focus on besides the scale
- Can you follow the eating window without feeling deprived or out of control?
- Are you getting enough protein, fiber, and fluids?
- Are hunger, energy, sleep, and mood stable?
- Are you avoiding binge eating during the 8-hour window?
- Do you have warning symptoms such as dizziness, shakiness, faintness, or missed periods?
How does 16:8 fasting work for weight loss?
Time-restricted eating works best when it helps you eat less overall without triggering rebound hunger. The 8-hour eating window is a structure, but total calories, protein, fiber, sleep, and activity still drive the long-term result 3, 4.
Time-restricted eating and calorie reduction
Many people lose weight on 16:8 because they cut out late-night snacks, sugary drinks, or extra meals. Reviews of intermittent fasting suggest weight loss is often linked to lower total energy intake, not a special fat-burning switch 3, 4.
Insulin, appetite, and meal timing: what the evidence can and cannot prove
Fasting changes when insulin rises and falls because insulin responds to meals. Some studies suggest intermittent fasting may improve metabolic markers in certain groups, including people with type 2 diabetes, but results differ by study design and population 2, 9.
For someone with prediabetes or metabolic syndrome, meal timing is only one piece. In the Diabetes Prevention Program, intensive lifestyle intervention reduced progression to type 2 diabetes in high-risk adults, showing that weight management, nutrition, and activity can matter for metabolic health 5. You can read more in our guides to weight loss for prediabetes and metabolic syndrome and weight loss.
Why eating-window food choices still matter
A fasting window does not cancel out frequent ultra-processed foods, low protein, or high-calorie drinks. If the 8-hour window becomes a rush to eat large portions, weight loss can stall even when the fasting window is consistent 3.
| Approach | What it may help with | What can go wrong |
|---|---|---|
| 16:8 fasting with balanced meals | Fewer eating opportunities, less late-night snacking, easier structure | May still be too restrictive for some people |
| 16:8 fasting with overeating in the window | May feel simple at first | Can erase the calorie gap needed for weight loss |
| Calorie awareness without fasting | More flexible timing and easier medication scheduling | Requires tracking or portion skills |
| Clinician-guided medical weight loss | Adds medical screening, medication review, and follow-up when appropriate | Requires eligibility review; medications can have side effects and contraindications |
What does clinical research show about 16:8 fasting?
Clinical research supports a cautious answer: 16:8 can help some people, but it is not clearly better for everyone than other ways of reducing calories. Most trials last more than 1 week, so they should not be used to promise first-week results 1, 2, 3.
What randomized trials show in adults with overweight or obesity
In the TREAT randomized clinical trial, adults with overweight or obesity assigned to time-restricted eating did not have a clearly greater weight-loss effect than the control group 1. This is important because it keeps expectations realistic: fasting is a tool, not a guarantee.
What studies show in people with type 2 diabetes
A randomized trial in adults with obesity and type 2 diabetes compared 16:8 and 14:10 intermittent fasting with a control group and found improvements in weight and some metabolic outcomes 2, 8. People with diabetes should not copy a fasting plan without medical guidance because glucose-lowering medications can raise hypoglycemia risk.
What systematic reviews suggest about intermittent fasting compared with calorie restriction
Systematic review evidence suggests intermittent fasting can produce weight loss, but the size of the effect varies by fasting type, comparison diet, and adherence 3. A larger review summarized by Harvard researchers also found intermittent fasting may be about as effective as traditional calorie restriction for weight and cardiometabolic measures, with differences by method 10.
Why study results may not predict your first week
Trial averages do not predict one person’s first 7 days. Starting weight, menstrual cycle timing, sodium intake, sleep, stress, constipation, alcohol, and medications can all change the short-term scale trend.
Does fasting from 7pm to 7am work?
7pm to 7am is a 12-hour overnight fast, not a 16:8 schedule. It may still help if it cuts late-night snacks, but it does not create the 16-hour fasting window used in 16:8 time-restricted eating.
Why 7pm to 7am is a 12-hour fast, not 16:8
A 16:8 plan means fasting for 16 hours and eating during 8 hours. If dinner ends at 7pm, a true 16-hour fast would place the next meal around 11am.
How a 12-hour overnight fast may still reduce late-night snacking
A 12-hour overnight fast can still be useful if it removes extra evening calories. For many people, the simple act of closing the kitchen after dinner improves consistency.
Examples of true 16:8 schedules
- 11am to 7pm eating window, then 7pm to 11am fasting window
- 12pm to 8pm eating window, then 8pm to 12pm fasting window
- 10am to 6pm eating window, then 6pm to 10am fasting window
If you want a broader comparison of fasting styles, our guide to the best intermittent fasting methods for weight loss explains 16:8, 5:2, alternate-day fasting, and other options.
What should you eat during the 8-hour window?
Food quality still matters during 16:8 fasting. A helpful first-week target is not perfection; it is getting enough protein, fiber, and fluid inside the 8-hour window without swinging into overeating.
Protein, fiber, and minimally processed foods
- Protein: eggs, Greek yogurt, fish, chicken, tofu, beans, lentils, or lean meats
- Fiber: vegetables, fruit, beans, lentils, oats, whole grains, nuts, and seeds
- Fluids: water, sparkling water, plain coffee, or unsweetened tea during the fasting window
- Meals: a balanced plate with protein, high-fiber carbohydrates, healthy fats, and vegetables
Why overeating during the eating window can cancel out weight loss
If fasting makes you so hungry that you eat much more later, the plan may not create a calorie gap. Reviews of intermittent fasting show that lower energy intake is one main reason weight loss happens, so the eating window still needs structure 3, 4.
Common first-week mistakes
- Too little protein, which can make hunger harder to manage
- Too little fluid, which can worsen headache or constipation
- Too much restriction, which can lead to rebound eating
- Breaking the fast with a very large meal after ignoring hunger for too long
- Using the fasting window to skip needed medications or meals that must be taken with food
How much weight can you lose in 1 month or 20 pounds with intermittent fasting?
One-month results are more useful than 1-week results because they smooth out water and digestion changes. Losing 20 pounds usually takes longer than most online claims suggest, and the safest pace depends on starting weight, health history, medications, and nutrition quality.
Why 1-month results are more meaningful than 1-week results
A month gives you enough time to see whether the schedule lowers total intake and feels repeatable. Clinical trials and reviews usually assess intermittent fasting over longer periods than one week, which is why first-week claims should be viewed with caution 1, 2, 3.
Why losing 20 pounds usually takes longer than most online claims suggest
Fast early losses may include water, not only fat. If a plan is so strict that it causes dizziness, binge eating, poor sleep, or missed periods, it may be unsafe or hard to sustain.
When a slower pace may be safer and easier to maintain
A slower plan may protect consistency, protein intake, strength, and lean mass. This is especially important for people with diabetes, older adults, people taking appetite-suppressing medication, or anyone with a history of disordered eating.
Who should be careful with 16:8 fasting?
16:8 fasting is not appropriate for everyone. People with diabetes, pregnancy or breastfeeding, adolescence, eating disorder history, or medications that must be taken with food should talk with a clinician before changing meal timing.
Diabetes medications and hypoglycemia risk
People using insulin or certain diabetes medications can have low blood sugar if meals are delayed. In diabetes studies of intermittent fasting, clinical context matters because participants are monitored and may have medication plans adjusted 2, 8, 9.
Pregnancy, breastfeeding, adolescence, and eating disorder history
Pregnancy, breastfeeding, growth during adolescence, and eating disorder recovery all raise nutrition needs or safety concerns. In these settings, fasting can create avoidable risk and should not be started without clinician guidance.
When fatigue, dizziness, binge eating, or missed periods are warning signs
Stop and seek medical guidance if fasting leads to fainting, repeated dizziness, binge eating, severe fatigue, missed periods, or fear around food. A weight-loss plan should support health, not make daily life feel unsafe.
3-min quiz
Need help deciding whether fasting is enough?
Chia offers online clinician evaluation for eligible patients considering medical weight-loss care, including compounded semaglutide injection and compounded tirzepatide tablets or injections. A prescription requires a medical evaluation and is not guaranteed. Compounded medications are not FDA-approved and are dispensed, when prescribed, through state-licensed 503A compounding pharmacies.
When should 16:8 fasting be paired with medical weight-loss care at Chia?
Medical weight-loss care may fit when lifestyle changes are not enough, weight-related conditions are present, or hunger makes consistency hard. At Chia, our providers review medical history, current medications, BMI, weight-related conditions, contraindications, and state rules before deciding whether treatment is appropriate.
When lifestyle changes are not enough or weight-related conditions are present
Lifestyle remains the foundation. In high-risk adults, intensive lifestyle intervention reduced progression to type 2 diabetes in the Diabetes Prevention Program 5. But some people need more support, especially when obesity, prediabetes, metabolic syndrome, or medication-related weight challenges are part of the picture.
How Chia evaluates eligibility for compounded semaglutide or compounded tirzepatide
Semaglutide is a GLP-1 receptor agonist; Wegovy and Ozempic are brand-name semaglutide products 11. Tirzepatide is a dual GIP/GLP-1 receptor agonist; Zepbound and Mounjaro are brand-name tirzepatide products 12. Compounded semaglutide and compounded tirzepatide are different products from the FDA-approved brand-name medications; compounded formulations are not FDA-approved and may be prescribed through licensed 503A pharmacies when clinically appropriate.
Active ingredients such as tirzepatide have been studied in randomized trials for metabolic outcomes, including insulin sensitivity markers in people with type 2 diabetes 6. Medication benefits and risks must be weighed with side effects such as nausea, vomiting, diarrhea, constipation, dehydration risk, gallbladder concerns, pancreatitis warnings, and contraindications; compounded formulations are not FDA-approved and do not have FDA-evaluated outcomes data.
For more background, see our guides to GLP-1 agonists for weight loss, semaglutide for weight loss, and tirzepatide weight-loss injections.
Microdosing GLP-1 options at Chia
Chia offers compounded semaglutide as an injection, with plans currently starting at $249/mo. Chia offers compounded tirzepatide as tablets or injections, with tablet plans currently starting at $249/mo and injection plans currently starting at $299/mo. Microdosing plans are available for semaglutide and tirzepatide when a provider decides they fit the patient’s goals and safety profile; compounded GLP-1 medications and microdosing plans are not FDA-approved.
| Chia option | Forms listed in Chia’s catalog | Current starting price | Notes |
|---|---|---|---|
| Compounded semaglutide | Injection | From $249/mo | Provider-guided dosing; microdosing plans available |
| Compounded tirzepatide | Tablets, injection | Tablets from $249/mo; injection from $299/mo | Provider-guided dosing; microdosing plans available |
| Weight + Energy protocol | NAD+ injection + choice of GLP-1 | From $309/mo | May be discussed during clinical review when energy goals and GLP-1 care overlap |
| Weight + Muscle protocol | Sermorelin injection + choice of GLP-1 | From $329/mo | May be discussed during clinical review when lean-mass support is a priority |
How online clinician review, 503A compounding, shipping, and portal messaging work
Chia is 100% online. You complete a short health questionnaire, then a licensed US provider reviews it and prescribes only when clinically appropriate. If prescribed, medication is compounded in the US by state-licensed 503A compounding pharmacies and shipped to your door. Patients can message the care team through the patient portal between visits.
When Chia’s Weight + Energy or Weight + Muscle protocols may be discussed
Some patients ask about fatigue, strength, or body composition while losing weight. During clinical review, Chia may discuss the Weight + Energy protocol, which includes NAD+ injection plus a choice of GLP-1, or the Weight + Muscle protocol, which includes sermorelin injection plus a choice of GLP-1, when the provider decides the protocol is appropriate. Compounded GLP-1 medications used in these protocols are not FDA-approved.
How can you track progress without overreacting to the first week?
Progress tracking should smooth out noise instead of amplifying it. A weekly average gives a better signal than one daily weigh-in, especially during the first week.
Use weekly weight averages instead of one daily weigh-in
If weighing yourself feels safe and not obsessive, weigh at the same time of day and look at the weekly average. If weighing triggers anxiety or disordered behavior, use non-scale markers instead and speak with a clinician.
Track waist measurement, hunger, energy, sleep, and consistency
- Waist measurement every 2 to 4 weeks
- Hunger before and after meals
- Energy during work, caregiving, and exercise
- Sleep quality and bedtime snacking
- How often you completed the eating window without rebound overeating
Know when to adjust your plan with a clinician
Adjust the plan if fasting causes dizziness, binge eating, medication problems, or poor nutrition. If you have prediabetes, diabetes, metabolic syndrome, or significant weight-related symptoms, clinician-guided care can help match the plan to your health history.
3-min quiz
Start a clinician-reviewed weight-loss plan
If 16:8 fasting has not been enough, Chia can evaluate whether medical weight-loss care fits your goals and health history. Options may include compounded semaglutide injection, compounded tirzepatide tablets or injections, or a protocol such as Weight + Energy or Weight + Muscle when clinically appropriate. A prescription is never guaranteed and requires review by a licensed US provider.
FAQ
Usually, not much true fat loss can be confirmed in 1 week. Some people see the scale drop from water, less food volume, or less sodium. Others see no change or a temporary increase. A weekly average over several weeks is more useful than a single first-week number.
You may lose belly fat over time if 16:8 helps you maintain a calorie deficit. You cannot choose where fat comes off first. Sleep, protein, strength training, alcohol intake, stress, and overall calories all affect waist changes.
First-week weight gain can come from sodium, constipation, sore muscles, menstrual cycle changes, larger meals during the eating window, or normal water shifts. It does not always mean fat gain. Look at the trend over several weeks.
Plain coffee, water, sparkling water, and unsweetened tea are commonly used during fasting windows. Adding sugar, cream, milk, or calorie-containing drinks can break the fast and may add calories that affect weight loss.
It can, if it lowers total calorie intake enough. Exercise is still helpful for heart health, insulin sensitivity, strength, mood, and preserving lean mass during weight loss.
Not for everyone. Some people prefer 16:8 because it gives a simple schedule. Others do better with calorie awareness, balanced meals, or a less strict eating window. The best plan is the one that is safe and repeatable.
If it feels safe, many people need several weeks to judge the trend. Stop sooner and talk with a clinician if you feel dizzy, develop binge eating, have low blood sugar symptoms, miss periods, or struggle to meet nutrition needs.
Sometimes, but it should be clinician-guided. GLP-1 medications can reduce appetite and cause nausea, vomiting, diarrhea, or constipation. Combining them with aggressive fasting or very low food intake can raise side-effect or nutrition risk. Compounded GLP-1 medications are not FDA-approved, and prescriptions require medical evaluation.
References
- 1.Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Internal Medicine. 2020.
- 2.Sukkriang N, Buranapin S. Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial. Journal of Diabetes Investigation. 2024.
- 3.Welton S, Minty R, O'Driscoll T, et al. Intermittent fasting and weight loss: Systematic review. Canadian Family Physician. 2020.
- 4.Patterson RE, Laughlin GA, LaCroix AZ, et al. Intermittent fasting and human metabolic health. Journal of the Academy of Nutrition and Dietetics. 2015.
- 5.Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine. 2002.
- 6.Frias JP, De Block C, Brown K, et al. Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2). The Journal of Clinical Endocrinology and Metabolism. 2024.
- 7.Horn DB, Linetzky B, Davies MJ, et al. Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity: A Post Hoc Analysis of the SURMOUNT-4 Trial. JAMA Internal Medicine. 2026.
- 8.Sukkriang N, Buranapin S. Effect of intermittent fasting 16:8 and 14:10 compared with control-group on weight reduction and metabolic outcomes in obesity with type 2 diabetes patients: A randomized controlled trial. Journal of Diabetes Investigation. 2024.
- 9.Guo L, Xi Y, Jin W, et al. A 5:2 Intermittent Fasting Meal Replacement Diet and Glycemic Control for Adults With Diabetes: The EARLY Randomized Clinical Trial. JAMA Network Open. 2024.
- 10.Harvard T.H. Chan School of Public Health. Intermittent fasting may be effective for weight loss, cardiometabolic health. 2025.
- 11.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2024.
- 12.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2023.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
